BREXPIPRAZOLE - Food and Drug Administration

Set ID
4f98ce54-9f30-4e8a-8455-2d3e352e5314
Type
Indexing - product concept
Effective date
2025-11-06
Version
2
Source
DailyMed source

Mapped DailyMed Labels#

Label, Relation, Manufacturer table
LabelRelationManufacturerEffective
These highlights do not include all the information needed to use REXULTI safely and effectively. See full prescribing information for REXULTI. REXULTI® (brexpiprazole) tablets, for oral use Initial U.S. Approval: 2015Product nameREMEDYREPACK INC.2026-09-18
These highlights do not include all the information needed to use REXULTI safely and effectively. See full prescribing information for REXULTI. REXULTI® (brexpiprazole) tablets, for oral use Initial U.S. Approval: 2015Product nameREMEDYREPACK INC.2026-06-02
These highlights do not include all the information needed to use REXULTI safely and effectively. See full prescribing information for REXULTI. REXULTI® (brexpiprazole) tablets, for oral use Initial U.S. Approval: 2015Product nameOtsuka America Pharmaceutical, Inc.2026-05-06
These highlights do not include all the information needed to use REXULTI safely and effectively. See full prescribing information for REXULTI. REXULTI® (brexpiprazole) tablets, for oral use Initial U.S. Approval: 2015Product nameREMEDYREPACK INC.2026-04-23
These highlights do not include all the information needed to use REXULTI safely and effectively. See full prescribing information for REXULTI. REXULTI® (brexpiprazole) tablets, for oral use Initial U.S. Approval: 2015Product nameREMEDYREPACK INC.2026-04-23
These highlights do not include all the information needed to use BREXPIPRAZOLE TABLETS safely and effectively. See full prescribing information for BREXPIPRAZOLE TABLETS. BREXPIPRAZOLE tablets, for oral use Initial U.S. Approval: 2015Product nameAjanta Pharma USA Inc. | Ajanta Pharma Limited | Ajanta Pharma Ltd., Dahej2022-12-13